Literature DB >> 69879

Maternal serum-alpha-fetoprotein and low birth-weight.

N Wald, H Cuckle, G M Stirrat, M J Bennett, A C Turnbull.   

Abstract

High maternal serum-alpha-fetoprotein (A.F.P.) concentrations in the first half of pregnancy were associated with prematurity and high perinatal mortality. 94 singleton pregnancies without neural-tube defects but with A.F.P. levels equal to or greater than three times the normal median resulted in the birth of infants weighing, on average, 357 g less than controls (P less than 0-001). The mean head circumference of the infants was also smaller than that of the controls. The 1 stillbirth and 3 neonatal deaths yielded a mortality-rate more than three and a half times that for singleton births without neural-tube defects at the same hospital in the years 1974-76. The results suggest that some pregnant women who will deliver low-birth-weight infants at high risk of perinatal death may be identified by means of serum-A.F.P. measurement early in pregnancy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 69879     DOI: 10.1016/s0140-6736(77)90953-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.

Authors:  W Fuhrmann; H K Weitzel
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

2.  Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.

Authors:  T A Doran; G H Valentine; P Y Wong; G Wielgosz; R J Benzie; H C Soltan; M R Jenner; P A Morland; R J Montgomery; L C Allen
Journal:  CMAJ       Date:  1987-08-15       Impact factor: 8.262

3.  The role of unexplained high serum alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in the second trimester to determine poor obstetric outcomes.

Authors:  Hümeyra Öztürk; Salim Erkaya; Sibel Altınbaş; Burak Karadağ; Nazan Vanlı Tonyalı; Demet Özkan
Journal:  Turk J Obstet Gynecol       Date:  2014-09-15

4.  Stress after amniocentesis for high serum alpha-fetoprotein concentrations.

Authors:  R Harris; A P Read; D Donnai; P Donnai
Journal:  Br Med J       Date:  1980-09-20

Review 5.  Maternal serum alphafetoprotein in pregnancy and the prevention of birth defect.

Authors:  R Harris
Journal:  Br Med J       Date:  1980-05-17

6.  Alpha-fetoprotein: a biochemical marker of fetal well-being.

Authors:  A Gupta; I C Verma; P S Menon
Journal:  Indian J Pediatr       Date:  1983 Mar-Apr       Impact factor: 1.967

7.  Severe pre-eclampsia of early onset.

Authors:  B N Walters; T T Lao; V A Smith; K Blau; M de Swiet
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-29

8.  Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.

Authors:  P H Persson; S Kullander; G Gennser; L Grennert; C B Laurell
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-05

Review 9.  Maternal serum screening for neural tube defects and fetal chromosome abnormalities.

Authors:  N C Rose; M T Mennuti
Journal:  West J Med       Date:  1993-09

Review 10.  Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis.

Authors:  Rachel K Morris; Jeltsje S Cnossen; Marloes Langejans; Stephen C Robson; Jos Kleijnen; Gerben Ter Riet; Ben W Mol; Joris A M van der Post; Khalid S Khan
Journal:  BMC Pregnancy Childbirth       Date:  2008-08-04       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.